Covered recipient · General Payments record
FOUAD ELJARRAH
Allopathic & Osteopathic Physicians Psychiatry & Neurology Psychiatry
General Payments · PY2019–2024
$781.89
- Reported across 45 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $207.16 | 12 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Indivior Inc. | $51.20 | 3 |
| Teva Pharmaceuticals USA, Inc. | $49.47 | 3 |
| Alkermes, Inc. | $21.73 | 1 |
| Tempus AI, Inc | $18.67 | 1 |
| ABBVIE INC. | $16.72 | 1 |
| Vanda Pharmaceuticals Inc. | $16.70 | 1 |
| E.R. Squibb & Sons, L.L.C. | $16.60 | 1 |
| Janssen Pharmaceuticals, Inc | $16.07 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (12)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $16.72 | 04/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103685929 | CMS |
| Alkermes, Inc. | $21.73 | 02/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120494671 | CMS |
| E.R. Squibb & Sons, L.L.C. | $16.60 | 11/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101250509 | CMS |
| Indivior Inc. | $16.76 | 01/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144527240 | CMS |
| Indivior Inc. | $16.66 | 04/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144527242 | CMS |
| Indivior Inc. | $17.78 | 07/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144527244 | CMS |
| Janssen Pharmaceuticals, Inc | $16.07 | 11/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078089408 | CMS |
| Tempus AI, Inc | $18.67 | 03/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150164179 | CMS |
| Teva Pharmaceuticals USA, Inc. | $15.41 | 05/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151654127 | CMS |
| Teva Pharmaceuticals USA, Inc. | $15.44 | 06/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151654165 | CMS |
| Teva Pharmaceuticals USA, Inc. | $18.62 | 10/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151654203 | CMS |
| Vanda Pharmaceuticals Inc. | $16.70 | 10/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133901855 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2019, 2020, 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.